Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Peripheral stem cell transplantation may be able to replace immune
cells that were destroyed by chemotherapy used to kill tumor cells, allowing higher doses of
chemotherapy to be used.
PURPOSE: Phase I/II trial to study the effectiveness of paclitaxel when added to high-dose
combination chemotherapy followed by peripheral stem cell transplantation in treating women
with breast cancer at high risk of relapse.